BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38358599)

  • 1. Loss of sCD3 in hepatosplenic T cell lymphoma - a- case report.
    Li J; Saydoon M; Rajagopal R; Jackson S
    J Hematop; 2022 Mar; 15(1):7-12. PubMed ID: 38358599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expect the unexpected - Loss of surface CD3 on flow cytometry in hepatosplenic T-cell lymphoma: An eye opener.
    Chauhan R; Tyagi S; Mirgh S; Mishra P; Seth T; Mahapatra M; Pati H; Saxena R
    Indian J Pathol Microbiol; 2018; 61(2):275-277. PubMed ID: 29676377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up.
    Jiang L; Abati AD; Wilson W; Stetler-Stevenson M; Yuan C
    Int J Clin Exp Pathol; 2009 Oct; 3(1):110-6. PubMed ID: 19918335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo CD3 negative hepatosplenic T-cell lymphoma: diagnostic challenges and pitfalls.
    Kapur LH; Khaled Y; Solh M; Ward D; Chang CC
    Arch Pathol Lab Med; 2014 Jul; 138(7):969-73. PubMed ID: 24978925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood sCD3⁻ CD4⁺ T cells: a useful diagnostic tool in angioimmunoblastic T cell lymphoma.
    Singh A; Schabath R; Ratei R; Stroux A; Klemke CD; Nebe T; Flörcken A; van Lessen A; Anagnostopoulos I; Dörken B; Ludwig WD; Pezzutto A; Westermann J
    Hematol Oncol; 2014 Mar; 32(1):16-21. PubMed ID: 23798351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of hepatosplenic gammadelta T cell lymphoma].
    Wang FX; Zhang XJ; Dong ZR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):505-8. PubMed ID: 15972153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese cases.
    Lu CL; Tang Y; Yang QP; Wang M; Zhao S; Bi CF; Jiang NG; Zhang WY; Liu JP; Xu X; Liu WP
    Hum Pathol; 2011 Dec; 42(12):1965-78. PubMed ID: 21683978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unusual presentation of an uncommon lymphoma, hepatosplenic T-cell lymphoma.
    Amin S; Findeis SK; Whiteley A; Krause JR
    Proc (Bayl Univ Med Cent); 2019 Jan; 32(1):129-130. PubMed ID: 30956608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic hepatosplenic gammadelta T-cell lymphoma following acute myeloid leukemia bearing two distinct gamma chains of the T-cell receptor. Biologic and clinical features.
    Weidmann E; Hinz T; Klein S; Schui DK; Harder S; Kriener S; Kabelitz D; Hoelzer D; Mitrou PS
    Haematologica; 2000 Oct; 85(10):1024-31. PubMed ID: 11025592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatosplenic gamma delta T-cell lymphoma. A distinctive aggressive lymphoma type.
    Wong KF; Chan JK; Matutes E; McCarthy K; Ng CS; Chan CH; Ma SK
    Am J Surg Pathol; 1995 Jun; 19(6):718-26. PubMed ID: 7755158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare case of hepatosplenic γδ T-cell lymphoma expressing CD19 with ring chromosome 7 and trisomy 8.
    Jain H; Shetty D; Jain H; Sengar M; Khattry N; Subramanian PG
    Cancer Genet; 2018 Dec; 228-229():17-20. PubMed ID: 30553467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin.
    Cooke CB; Krenacs L; Stetler-Stevenson M; Greiner TC; Raffeld M; Kingma DW; Abruzzo L; Frantz C; Kaviani M; Jaffe ES
    Blood; 1996 Dec; 88(11):4265-74. PubMed ID: 8943863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatosplenic T-cell lymphoma of alphabeta lineage in a 16-year-old boy presenting with hemolytic anemia and thrombocytopenia.
    Lai R; Larratt LM; Etches W; Mortimer ST; Jewell LD; Dabbagh L; Coupland RW
    Am J Surg Pathol; 2000 Mar; 24(3):459-63. PubMed ID: 10716161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatosplenic gammadeltaT-cell lymphoma: a clinicopathological study].
    Geng J; Zhu MG; Ding YQ; Han HX
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):88-90. PubMed ID: 14724108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous hepatosplenic T-cell lymphoma and myelofibrosis.
    Gabali AM; Jazaerly T; Chang CC; Cleveland R; Kass L
    Avicenna J Med; 2014 Apr; 4(2):34-6. PubMed ID: 24761381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Unusual Case of Hepatosplenic αβ T-Cell Lymphoma Presenting with Coombs'-Negative Hemolytic Anemia.
    Ibrahim FA; Shanmugam V; Amer A; El-Omri H; Al-Sabbagh A; Taha RY; Soliman DS
    Clin Med Insights Oncol; 2015; 9():123-8. PubMed ID: 26688667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatosplenic gamma delta T-cell lymphoma in a boy with visceral leishmaniasis: a case report.
    Mutreja D; Kotru M; Aggarwal M; Tejwani N; Sharma RK; Pati HP
    J Med Case Rep; 2013 Dec; 7():269. PubMed ID: 24330681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic Expression of CD3ε Heterodimers by Flow Cytometry Rapidly Distinguishes Between Mature T-Cell and Natural Killer-Cell Neoplasms.
    Shi M; Nguyen P; Timm MM; Otteson GE; Horna P; Olteanu H; Jevremovic D
    Am J Clin Pathol; 2020 Oct; 154(5):683-691. PubMed ID: 32589191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.